American College of Sports Medicine (2009) ACSM’s Guidelines for Exercise Testing and Prescription. New York. Lippincott Williams & Wilkin. |
Balciunas M., Bagdonaite L., Samalavicius R., Baublys A. (2009) Markers of endothelial dysfunction after cardiac surgery: soluble forms of vascular-1 and intercellular-1 adhesion molecules. Medicina (Kaunas) 445, 434-439. |
Bartzeliotou A.I., Margeli A.P., Tsironi M., Skenderi K., Bacoula C., Chrousos G.P., Papassotiriou I. (2007) Circulating levels of adhesion molecules and markers of endothelial activation in acute inflammation induced by prolonged brisk exercise. Clinical Biochemistry 440, 765-770. |
Bernecker C., Scherr J., Schinner S., Braun S., Scherbaum W.A., Halle M. (2011) Evidence for an exercise induced increase of TNF-alpha and IL-6 in marathon runners. Scandinavian Journal of Medicine & Science in Sports , -. |
Blake G.J., Ridker P.M. (2001) Novel clinical markers of vascular wall inflammation. Circulation Research 889, 763-771. |
Bolad I., Delafontaine P. (2005) Endothelial dysfunction: its role in hypertensive coronary disease. Current Opinion in Cardiology 220, 270-274. |
Burke A.P., Farb A., Malcom G.T., Liang Y., Smialek J.E., Virmani R. (1999) Plaque rupture and sudden death related to exertion in men with coronary artery disease. The Journal of the American Medical Association 2281, 921-926. |
Di Francescomarino S., Sciartilli A., Di Valerio V., Di Baldassarre A., Gallina S. (2009) The effect of physical exercise on endothelial function. Sports Medicine 339, 797-812. |
Dill D.B., Costill D.L. (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. Journal of Applied Physiology 337, 247-248. |
Dschietzig T., Brecht A., Bartsch C., Baumann G., Stangl K., Alexiou K. (2012) Relaxin improves TNF-alpha-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling. Cardiovascular Research 995, 97-107. |
Dunn A.L., Marcus B.H., Kampert J.B., Garcia M.E., Kohl H.W., Blair S.N. (1997) Reduction in cardiovascular disease risk factors: 6-month results from Project Active. Preventive Medicine 226, 883-892. |
Endemann D.H., Schiffrin E.L. (2004) Endothelial dysfunction. Journal of the American Society of Nephrology 115, 1983-1992. |
Febbraio M.A., Pedersen B.K. (2002) Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB Journal 116, 1335-1347. |
Fortescue E.B., Shin A.Y., Greenes D.S., Mannix R.C., Agarwal S., Feldman B.J., Shah M.I., Rifai N., Landzberg M.J., Newburger J.W., Almond C.S. (2007) Cardiac troponin increases among runners in the Boston Marathon. Annals of Emergency Medicine 449, 137-143. |
Goel R., Majeed F., Vogel R., Corretti M.C., Weir M., Mangano C., White C., Plotnick G.D., Miller M. (2007) Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner. American Journal of Cardiology 999, 743-744. |
Goussetis E., Spiropoulos A., Tsironi M., Skenderi K., Margeli A., Graphakos S., Baltopoulos P., Papassotiriou I. (2009) Spartathlon, a 246 kilometer foot race: effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells. Blood Cells, Molecules, & Diseases 442, 294-299. |
Jaakkola K., Jalkanen S., Kaunismaki K., Vanttinen E., Saukko P., Alanen K., Kallajoki M., Voipio-Pulkki L.M., Salmi M. (2000) Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. Journal of the American College of Cardiology 336, 122-129. |
Kim H.J., Lee Y.H., Kim C.K. (2007) Biomarkers of muscle and cartilage damage and inflammation during a 200 km run. European Journal of Applied Physiology 999, 443-447. |
La Gerche A., Boyle A., Wilson A.M., Prior D.L. (2004) No evidence of sustained myocardial injury following an Ironman distance triathlon. International Journal of Sports Medicine 225, 45-49. |
Margeli A., Skenderi K., Tsironi M., Hantzi E., Matalas A.L., Vrettou C., Kanavakis E., Chrousos G., Papassotiriou I. (2005) Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. The Journal of Clinical Endocrinology and Metabolism 990, 3914-3918. |
Maron B.J., Poliac L.C., Roberts W.O. (1996) Risk for sudden cardiac death associated with marathon running. Journal of the American College of Cardiology 228, 428-431. |
Marsh S.A., Coombes J.S. (2005) Exercise and the endothelial cell. Int J Cardiol 999, 165-169. |
Maughan R.J., Whiting P.H., Davidson R.J. (1985) Estimation of plasma volume changes during marathon running. British Journal of Sports Medicine 119, 138-141. |
Meldrum D.R., Cleveland J.C., Cain B.S., Meng X., Harken A.H. (1998) Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. The Annals of Thoracic Surgery 665, 439-443. |
Mobius-Winkler S., Hilberg T., Menzel K., Golla E., Burman A., Schuler G., Adams V. (2009) Time-dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. Journal of Applied Physiology 1107, 1943-1950. |
Mora S., Cook N., Buring J. E., Ridker P.M., Lee I.M. (2007) Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 1116, 2110-2118. |
Nielsen H.G., Lyberg T. (2004) Long-distance running modulates the expression of leucocyte and endothelial adhesion molecules. Scandinavian Journal of Immunology 660, 356-362. |
Nieman D.C., Dumke C.L., Henson D.A., McAnulty S.R., Gross S.J., Lind R.H. (2005) Muscle damage is linked to cytokine changes following a 160-km race. Brain, Behavior, and Immunity 119, 398-403. |
Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. (1999) Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. The Journal of Physiology 5515, 287-291. |
Pedersen B.K., Akerstrom T.C., Nielsen A.R., Fischer C.P. (2007) Role of myokines in exercise and metabolism. Journal of Applied Physiology 1103, 1093-1098. |
Pedersen B. K., Febbraio M. A. (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews 888, 1379-1406. |
Pedersen B.K., Hoffman-Goetz L. (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiological Reviews 880, 1055-1081. |
Pedersen B.K., Steensberg A., Schjerling P. (2001) Exercise and interleukin-6. Current Opinion in Hematology 88, 137-141. |
Petersen A.M., Pedersen B.K. (2005) The anti-inflammatory effect of exercise. J Appl Physiol 998, 1154-1162. |
Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., Zhang C. (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circulation Research 999, 69-77. |
Porreca E., Di Febbo C., di Castelnuovo A., Baccante G., Amore C., Angelini A., Di Nisio M., Donati M., Cuccurullo F., Iacoviello L. (2002) Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. Atherosclerosis 1165, 159-166. |
Pue C.A., Mortensen R.F., Marsh C.B., Pope H.A., Wewers M.D. (1996) Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. The Journal of Immunology 1156, 1594-1600. |
Rehman J., Li J., Orschell C.M., March K.L. (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 1107, 1164-1169. |
Scherr J., Braun S., Schuster T., Hartmann C., Moehlenkamp S., Wolfarth B., Pressler A., Halle M. (2011) 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Medicine and Science in Sports and Exercise 443, 1819-1827. |
Scott J.M., Esch B.T., Shave R., Warburton D.E., Gaze D., George K. (2009) Cardiovascular consequences of completing a 160-km ultramarathon. Medicine and Science in Sports and Exercise 441, 26-34. |
Siegel A.J. (1997) Relative risk of sudden cardiac death during marathon running. Archives of Internal Medicine 1157, 1269-1270. |
Silvestro A., Brevetti G., Schiano V., Scopacasa F., Chiariello M. (2005) Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thrombosis and haemostasis 93, 559-563. |
Smith L.L. (2000) Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress?. Medicine and Science in Sports and Exercise 32, 317-331. |
Stewart K.J., Sung J., Silber H.A., Fleg J.L., Kelemen M.D., Turner K.L., Bacher A.C., Dobrosielski D.A., DeRegis J.R., Shapiro E.P., Ouyang P. (2004) Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. American Journal of Hypertension 117, 314-320. |
Suzuki K., Nakaji S., Yamada M., Liu Q., Kurakake S., Okamura N., Kumae T., Umeda T., Sugawara K. (2003) Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Medicine and Science in Sports and Exercise 335, 348-355. |
Suzuki K., Totsuka M., Nakaji S., Yamada M., Kudoh S., Liu Q., Sugawara K., Yamaya K., Sato K. (1999) Endurance exercise causes interaction among stress hormones, cytokines, neutrophil dynamics, and muscle damage. Journal of Applied Physiology 887, 1360-1367. |
Tousoulis D., Charakida M., Stefanadis C. (2008) Endothelial function and inflammation in coronary artery disease. Postgraduate Medicine Journal 884, 368-371. |
van Beaumont W., Underkofler S., van Beaumont S. (1981) Erythrocyte volume, plasma volume, and acid-base changes in exercise and heat dehydration. Journal of Applied Physiology 50, 1255-1262. |
van Bussel B.C., Schouten F., Henry R.M., Schalkwijk C.G., de Boer M.R., Ferreira I., Smulders Y.M., Twisk J.W., Stehouwer C.D. (2011) Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 558, 588-595. |
Vermeire S., Van Assche G., Rutgeerts P. (2004) C-reactive protein as a marker for inflammatory bowel disease. Inflammation Bowel Disease 110, 661-665. |
|